TRV GP III’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,962,202
| Closed | -$14.3M | – | 4 |
|
|
2022
Q4 | $14.3M | Sell |
1,962,202
-2,000,000
| -50% | -$14.6M | 11.2% | 4 |
|
|
2022
Q3 | $32.1M | Hold |
3,962,202
| – | – | 14% | 4 |
|
|
2022
Q2 | $19.4M | Hold |
3,962,202
| – | – | 7.94% | 5 |
|
|
2022
Q1 | $93.7M | Hold |
3,962,202
| – | – | 25.43% | 2 |
|
|
2021
Q4 | $70.1M | Sell |
3,962,202
-1,000,000
| -20% | -$17.7M | 17.54% | 4 |
|
|
2021
Q3 | $140M | Sell |
4,962,202
-1,000,000
| -17% | -$28.2M | 26.57% | 2 |
|
|
2021
Q2 | $62.5M | Hold |
5,962,202
| – | – | 10.91% | 4 |
|
|
2021
Q1 | $70.2M | Hold |
5,962,202
| – | – | 8.88% | 4 |
|
|
2020
Q4 | $69.8M | Hold |
5,962,202
| – | – | 6% | 5 |
|
|
2020
Q3 | $47.3M | Hold |
5,962,202
| – | – | 3.97% | 6 |
|
|
2020
Q2 | $109M | Hold |
5,962,202
| – | – | 15.92% | 3 |
|
|
2020
Q1 | $71.2M | Hold |
5,962,202
| – | – | 19.37% | 2 |
|
|
2019
Q4 | $99.2M | Hold |
5,962,202
| – | – | 43.81% | 1 |
|
|
2019
Q3 | $39.6M | Buy |
+5,962,202
| New | +$39.6M | 22.43% | 2 |
|